Exelixis Inc
(NAS:EXEL)
$
56.51
-0.60 (-1.05%)
Market Cap: 14.20 Bil
Enterprise Value: 13.59 Bil
PE Ratio: 18.77
PB Ratio: 7.40
GF Score: 92/100 Exelixis Inc at RBC Capital Markets Global Healthcare Conference Transcript
May 19, 2026 / 01:00PM GMT
Release Date Price:
$48.67
(-2.35%)
Leonid Timashev
RBC Capital Markets Inc - Equity Analyst
Our second session, we've got Exelixis, and we're really excited to have them here. They're represented by Andrew Peters is the SVP of Strategy. Thanks for being here.
Andrew Peters
Exelixis Inc - Senior Vice President, Strategy
Yes. Thanks for the invite. Glad to be here.
Questions & Answers
Leonid Timashev
RBC Capital Markets Inc - Equity Analyst
Yes. So a lot going on at the company. I wanted to start maybe on the commercial franchises first. So you guys have given guidance cabo had a pretty solid quarter. So maybe at a high level, I mean, how are you thinking about the balance of the year, the future trajectory this year for cabo across its existing indications.
Andrew Peters
Exelixis Inc - Senior Vice President, Strategy
Yes. Happy to get into that, I guess, before answering, I want to make sure that everyone understands going to be making forward-looking statements today, so please see our
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot